Snapshot of Australian JIA shows high remission rates

Modern therapies are effective but flares and relapse are common, researchers say

Children with juvenile idiopathic arthritis being treated at Australia’s largest paediatric rheumatology clinic have high rates of remission at 12 months, according to study results.

But the analysis of data at the Royal Children’s Hospital  in Melbourne shows there is a significant relapse rate and a requirement for ongoing medication.